DC
TPST icon

Deere & Company’s Tempest Therapeutics TPST Stock Holding History

Deere & Company’s Portfolio TPST Stock Details TPST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-4
Closed -$403K – 1107
2015
Q1 		$403K Hold
4
– – 0.02% 704
2014
Q4 		$513K Buy
+4
New +$293K 0.03% 595

Other funds holding TPST

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Jennison Associates
Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
OH
Orbis Holdings Hamilton, Bermuda $12.8B AUM 8.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
KCM
Kingdon Capital Management New York $911M AUM 51.11% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Deere & Company's TPST Position: Q2 2015 in Review

Deere & Company sold out of Tempest Therapeutics (TPST) in Q2 2015, closing a stake of 4 shares — an estimated $403K sold.

Deere & Company first reported a position in TPST in Q4 2014 and held it in 2 quarters. The position peaked at $513K in Q4 2014. 92 funds tracked by Wall St. Rank hold TPST as of Q2 2015.

  • Deere & Company reported no remaining Tempest Therapeutics position as of Q2 2015 after selling out during the quarter.
  • Deere & Company sold 4 Tempest Therapeutics shares in Q2 2015, an estimated $403K.
  • Deere & Company first reported a position in Tempest Therapeutics in Q4 2014 and held it in 2 quarters.
  • Deere & Company's Tempest Therapeutics position peaked at $513K in Q4 2014.
  • 92 funds tracked by Wall St. Rank held Tempest Therapeutics as of Q2 2015.

Based on Deere & Company's 13F filing for Q2 2015, filed 13 Aug 2015.